Bicuculline

Bicuculline

SCHEMBL5481014

CN1CCc2cc3c(cc2C1C1OC(=O)c2c1ccc1c2OCO1)OCO3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 1.00
CYP2C9 P11712 6/20 1.00
CYP2C19 P33261 6/20 1.00
CYP2D6 P10635 6/20 1.00
TSHR P16473 4/20 1.00
CYP1A2 P05177 3/20 1.00
LMNA P02545 3/20 1.00
HIF1A Q16665 1/20 1.00
GABRP O00591 1/20 1.00
GABRD O14764 1/20 1.00
GABRA1 P14867 1/20 1.00
GABRB1 P18505 1/20 1.00
GABRG2 P18507 1/20 1.00
GABRB3 P28472 1/20 1.00
GABRA5 P31644 1/20 1.00
GABRA3 P34903 1/20 1.00
GABRA2 P47869 1/20 1.00
GABRB2 P47870 1/20 1.00
GABRA4 P48169 1/20 1.00
GABRE P78334 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicuculline SCHEMBL28213750 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL29652597 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL29617593 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL29390611 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL7913545 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL5783586 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL8222 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL29366341 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL16320040 1.00 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
Bicuculline SCHEMBL2532354 0.99 CYP3A4 (0.98) CYP3A4CYP2C9CYP2C19CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10835513-B2 Methods and treatments for the learning and memory deficits associated with Noonan syndrome THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-11-17 US disclosed
US-20120283323-A1 Treating Learning Deficits with Inhibitors of HMG CoA Reductase NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-11-08 US disclosed
US-8222293-B2 Treating learning deficits with inhibitors of Hmg CoA reductase Regents of the University of Carolina (US) 2012-07-17 US disclosed
US-20070299096-A1 Treating Learning Deficits With Inhibitors of Hmg CoA Reductase REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-12-27 US disclosed
WO-2005120496-A2 TREATING LEARNING DEFICITS WITH INHIBITORS OF HMG CoA REDUCTASE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-12-22 WO disclosed